Pharma
Sterile Manufacturing & Fill-Finish Asia
- Date
- 12–13 October 2027
- Location
- Singapore
Event information
- Date
- 12–13 October 2027
- Location
- Singapore
Overview
Asia is becoming an increasingly important hub for sterile pharmaceutical and biopharmaceutical manufacturing, driven by the growth of biologics, vaccines, complex injectables and other high-value sterile medicines. Across the region, manufacturers are investing in advanced aseptic processing, barrier technologies, automation and flexible fill-finish capabilities to strengthen sterility assurance, manufacturing efficiency and supply resilience.
From Singapore's established pharmaceutical manufacturing base and South Korea's rapidly expanding biologics capacity, to Japan's advanced pharmaceutical industry, India's large-scale injectable manufacturing capabilities and the growing pharmaceutical sectors across Southeast Asia, the region is seeing continued development across sterile drug-product manufacturing. These investments are creating greater demand for advanced filling technologies, isolators and RABS, contamination-control solutions, inspection systems, primary packaging and increasingly automated manufacturing operations.
Taking place on 12–13 October 2027 in Singapore, Sterile Manufacturing & Fill-Finish Asia 2027 will bring together pharmaceutical and biopharmaceutical manufacturers, CDMOs, technology providers and industry experts from Singapore, South Korea, Japan, China, India, Taiwan, Southeast Asia and the wider Asia-Pacific region to exchange expertise and address the evolving technical and operational challenges of sterile manufacturing.
The conference will explore aseptic processing, contamination control, isolators and RABS, sterile filtration, fill-finish process development, lyophilisation, primary packaging, visual inspection, quality and validation, automation and digital manufacturing — providing a focused platform to discover new technologies, share manufacturing strategies and advance the next generation of sterile manufacturing and fill-finish across Asia.
Programme
Day 1 — Tuesday 12 October 2027
- 08:30
Registration & Welcome Coffee
- 09:00
Chairperson's Welcome & Opening Remarks
- 09:10
SESSION I - THE FUTURE OF STERILE MANUFACTURING IN ASIA
- 10:25
Morning Networking Break & Exhibition Viewing
- 11:10
SESSION II: CONTAMINATION CONTROL, FACILITY DESIGN & STERILITY ASSURANCE
- 12:25
Networking Lunch & Exhibition Viewing
- 13:40
SESSION III: ASEPTIC PROCESSING, ISOLATORS, RABS & ROBOTICS
- 14:55
Afternoon Networking Coffee & Exhibition Viewing
- 15:40
SESSION IV: FILL-FINISH PROCESS DEVELOPMENT & TECHNOLOGY TRANSFER
- 17:00
End of Day 1 — Sterile Manufacturing & Fill-Finish Asia 2027, Networking Reception
Day 2 — Wednesday 13 October 2027
- 09:10
SESSION V: STERILE FILTRATION, LYOPHILISATION & COMPLEX FORMULATIONS
- 10:25
Morning Networking Break & Exhibition Viewing
- 11:10
SESSION VI: PRIMARY PACKAGING, CONTAINER CLOSURE & VISUAL INSPECTION
- 12:25
Networking Lunch & Exhibition Viewing
- 13:40
SESSION VII: QUALITY, VALIDATION & REGULATORY READINESS
- 14:55
Afternoon Networking Coffee & Exhibition Viewing
- 15:40
SESSION VIII: MANUFACTURING EXCELLENCE, AUTOMATION & THE FUTURE OF FILL-FINISH
- 17:00
End of Conference
Who Attends
By Company Profile
- Pharma & Big Pharma45%
- Technology / Solution Providers25%
- CDMOs / CMOs15%
- Pharma / Injectable & Sterile Drug Manufacturers10%
- Government / Academics / Research Institutes / Associations5%
By Job Function
- Sterile Manufacturing / Fill-Finish / Manufacturing Operations25%
- Quality Assurance / QC / Sterility Assurance / Microbiology18%
- Process Development / MSAT / Technology Transfer15%
- Engineering / Facilities / Automation12%
- Aseptic Processing / Contamination Control / Validation10%
- Packaging / Device / Visual Inspection8%
- CMC / Regulatory / Supply Chain / Procurement5%
- Others / BD / Marketing / Management7%
Country / Market
- Singapore30%
- Malaysia / Thailand / Indonesia / Vietnam / Philippines25%
- South Korea / Japan15%
- China / Taiwan / Hong Kong15%
- India / Australia / New Zealand15%
- US / Europe / Others5%
Media Partners
Want to Sponsor This Event?
Explore sponsorship opportunities and discover how your brand can connect with key decision-makers across the industry.
Speak with our Sponsorship Team
Register
Contact us for group bookings of three or more delegates.
| Delegate Category | Super Early Bird Rate Valid until 30th June 2027 | Early Bird Rate Valid until 31st August 2027 | Standard Rate |
|---|---|---|---|
| Pharma, Big Pharma, Academics, Research Institutes & Government | SGD 699 | SGD 899 | SGD 1,099 |
| Service & Solution Provider | SGD 2,049 | SGD 2,249 | SGD 2,449 |
INSIGHTS
Read before you go
- PharmaMarket insight
How the Revised EU GMP Annex 1 Is Reshaping Sterile Fill-Finish in Asia
The revised EU GMP Annex 1 has moved sterile manufacturing from a checklist of controls to a documented, site-wide contamination control strategy. This article looks at what the revision changed, why it matters well beyond Europe, and how manufacturers and CDMOs across Asia are responding with barrier technology, automation and new fill-finish investment.
Read more: How the Revised EU GMP Annex 1 Is Reshaping Sterile Fill-Finish in Asia - BiopharmaIndustry article
Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia
On 12 November 2026, Eppendorf SE broke ground on a new production facility at Bandar Cassia Technology Park in Penang. The EUR 40 million investment is the company's first manufacturing operation in Southeast Asia and will produce selected products from its Centrifuges & Instruments portfolio for laboratories worldwide, with production starting gradually in 2028.
Read more: Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia - BiopharmaMarket insight
Genome Editing in Asia: Can the Region Turn CRISPR Science into Accessible Therapies?
The first approved CRISPR therapy proved that genome editing can work as a medicine. Asia, home to a large share of the world's patients with inherited blood disorders and a fast-growing research base, is now moving from discovery towards the clinic. This article looks at where the region stands, what is holding it back and what to watch next.
Read more: Genome Editing in Asia: Can the Region Turn CRISPR Science into Accessible Therapies?



